Johnson & Johnson's OTTAVA Robotic Surgical System Approved by FDA

Johnson & Johnson has secured FDA market authorization in the U.S. for its innovative OTTAVA Robotic Surgical System. This approval marks the company's entry into the competitive American robotic surgery sector. The OTTAVA system distinguishes itself by integrating robotic arms directly into the operating table, which is designed to significantly reduce the required surgical footprint by up to 50%.